Gold‐Functionalized Multilayer Heterojunction Microarchitectures Enable High‐Fidelity Serum Metabolite Profiling for Skin Cancer Subtype Classification
Small Methods · 2026
DOI: 10.1002/smtd.70782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2026. Verfasst von Daili Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China. Hauptthemen laut MEDLINE: Gold, Skin Neoplasms, Metabolomics, Metabolome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Science Foundation of Zhejiang Province, National K & D Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Skin cancer is among the most prevalent malignancies worldwide, with non‐melanoma types ranking among the top five and melanoma characterized by high lethality. Psoriasis, although non‐malignant, imposes a substantial physical and psychological burden. Accurate and timely detection is crucial for improving clinical outcomes. Serum metabolites, as sensitive indicators of systemic physiology, represent promising noninvasive biomarkers. Here, we developed gold‐modified rose‐like multilayer heterojunctions (G‐RMHJ) as an efficient matrix for laser desorption/ionization mass spectrometry (LDI‐MS). The hierarchical multilayer architecture and heterojunction interfaces, combined with gold functionalization, synergistically enhance light absorption, interfacial energy transfer, and ionization efficiency, enabling sensitive and reproducible serum metabolite detection. In a cohort of 130 skin cancer and 23 psoriasis patients together with 218 healthy controls (HC), G‐RMHJ‐assisted LDI‐MS yielded robust serum metabolic fingerprints, and machine learning models built on these data achieved 100% test‐set accuracy for classifying patients vs. HC. Eight discriminative metabolites were identified that reliably differentiated four types of diseases from HC, with area under the curve values ranging from 0.933 to 1.000. This work demonstrates how hierarchical microstructured heterojunctions can directly translate materials‐level design into enhanced bioanalytical performance, providing a generalizable and noninvasive framework for serum metabolomics–based disease classification and skin cancer subtype identification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Materials Science and Chemical Engineering, Ningbo University, Ningbo, China.
- The First Affiliated Hospital of Ningbo University, Ningbo, Zhejiang, China.
- Center for Medical Research and Innovation, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
- Department of Chemistry, Fudan University, Shanghai, China.
ORCID-Profile: Yinghua Yan, Chunhui Deng
Förderung
- Natural Science Foundation of Zhejiang Province
- National K & D Program of China
- National Natural Science Foundation of China
- Ningbo Major Public Welfare Science and Technology Project
Zitieren
APA
Gao, D., Liu, Z., Li, X., Li, Z., Liu, C., Ding, C. F., Yan, Y., Shi, F., & Deng, C. (2026). Gold‐Functionalized Multilayer Heterojunction Microarchitectures Enable High‐Fidelity Serum Metabolite Profiling for Skin Cancer Subtype Classification. Small Methods. https://doi.org/10.1002/smtd.70782
Vancouver
Gao D, Liu Z, Li X, Li Z, Liu C, Ding CF, et al. Gold‐Functionalized Multilayer Heterojunction Microarchitectures Enable High‐Fidelity Serum Metabolite Profiling for Skin Cancer Subtype Classification. Small Methods. 2026. doi:10.1002/smtd.70782
BibTeX
@article{Gao2026,
author = {Gao, Daili and Liu, Zihao and Li, Xinyi and Li, Zherui and Liu, Chunbo and Ding, Chuan-Fan and Yan, Yinghua and Shi, Fangying and Deng, Chunhui},
title = {Gold‐Functionalized Multilayer Heterojunction Microarchitectures Enable High‐Fidelity Serum Metabolite Profiling for Skin Cancer Subtype Classification},
journal = {Small Methods},
year = {2026},
doi = {10.1002/smtd.70782}
}
EUVIMED